Several ocular findings in AD have been identified, including amyloid precursor protein (APP) and amyloid-beta degradation products in human corneal epithelial cells and fibroblasts, suggesting that APP metabolism and AD-related protein presence in the cornea may serve as potential markers for diagnosing Alzheimer’s disease [10]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.